VEGFA and myocardial infarction: The local precise release of AACs decreased the inflammatory response and lowered cardiomyocyte death in a rat model of MI with the intramyocardial treatment of an injectable hydrogel carrying AACs and VEGF (Zhang et al., 2021c) (Figure 10C).